CoChat

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma

Open access
Jiang, Zhe, Zacksenhaus, Eldad · 2002 · The Journal of Cell Biology

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Abstract

The retinoblastoma (Rb) tumor suppressor controls cellular proliferation, survival, and differentiation and is functionally inactivated by mutations or hyperphosphorylation in most human cancers. Although activation of endogenous Rb is thought to provide an effective approach to suppress cell proliferation, long-term inhibition of apoptosis by active Rb may have detrimental consequences in vivo. To directly test these paradigms, we targeted phosphorylation-resistant constitutively active Rb alleles, RbΔKs, to the mouse mammary gland. Pubescent transgenic females displayed reduced ductal elongation and cell proliferation at the endbuds. Postpuberty transgenic mice exhibited precocious cellular differentiation and β-casein expression and extended survival of the mammary epithelium with a moderate but specific effect on the expression of E2F1, IGF1Rα, and phospho–protein kinase B/AKT. Remarkably, ∼30% RbΔK transgenic females developed focal hyperplastic nodules, and ∼7% exhibited full-blown mammary adenocarcinomas within 15 mo. Expression of the RbΔK transgene in these mammary tumors was reduced greatly. Our results suggest that transient activation of Rb induces cancer by extending cell survival and that the dual effects of Rb on cell proliferation and apoptosis impose an inherent caveat to the use of the Rb pathway for long-term cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200106084

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Targeted expression of constitutively active Rb to the mammary gland. (A) Schematic structure of Rb showing the pocket domain (A and B), relative location of 16 Cdk phosphoacceptor sites, and mutated residues in RbΔp34 and RbΔK11. (B) Schematic presentation of the MMTV-RbΔp34 and MMTV-RbΔK11 transgenes. (C) Detection of RbΔK transgene by Northern blot analysis. The transgene has a shorter 3′ UTR and migrates faster. (D and F) Western blots of protein lysates (50 μg) from mammary glands of (D) 13-wk-old or (F) 14-mo-old transgenic and wild-type females were developed with anti-HA monoclonal antibody. (E) Protein lysates (1.2 mg) from 14-mo-old transgenic and control mammary glands were immunoprecipitated with anti-HA antibodies and Western blotted with anti-Rb antibody. (G and H) RT-PCR analysis of the MMTV-RbΔp34#24 and MMTV-RbΔK11#29 transgenes relative to keratin 18 in virgin (V), pregnant (P), lactating (Lac), and involuting (Inv) glands. w, weeks. + and − signs indicate the presence or absence of reverse transcriptase.
Figure 1. Targeted expression of constitutively active Rb to the mammary gland. (A) Schematic structure of Rb showing the pocket domain (A and B), relative location of 16 Cdk phosphoacceptor sites, and mutated residues in RbΔp34 and RbΔK11. (B) Schematic presentation of the MMTV-RbΔp34 and MMTV-RbΔK11 transgenes. (C) Detection of RbΔK transgene by Northern blot analysis. The transgene has a shorter 3′ UTR and migrates faster. (D and F) Western blots of protein lysates (50 μg) from mammary glands of (D) 13-wk-old or (F) 14-mo-old transgenic and wild-type females were developed with anti-HA monoclonal antibody. (E) Protein lysates (1.2 mg) from 14-mo-old transgenic and control mammary glands were immunoprecipitated with anti-HA antibodies and Western blotted with anti-Rb antibody. (G and H) RT-PCR analysis of the MMTV-RbΔp34#24 and MMTV-RbΔK11#29 transgenes relative to keratin 18 in virgin (V), pregnant (P), lactating (Lac), and involuting (Inv) glands. w, weeks. + and − signs indicate the presence or absence of reverse transcriptase.CC BY-NC-SA · PubMed Central
Figure 2. Temporal expression of endogenous Rb during mammogenesis in wild-type females. (A–F) RNA In situ hybridization analysis of endogenous Rb. Shown are bright field (A, C, and E) and dark field (B, D, and F) micrographs of representative sections. (G–I) IHC of endogenous Rb in wild-type mammary glands. Arrows indicate Rb-positive nuclei.
Figure 2. Temporal expression of endogenous Rb during mammogenesis in wild-type females. (A–F) RNA In situ hybridization analysis of endogenous Rb. Shown are bright field (A, C, and E) and dark field (B, D, and F) micrographs of representative sections. (G–I) IHC of endogenous Rb in wild-type mammary glands. Arrows indicate Rb-positive nuclei.CC BY-NC-SA · PubMed Central
Figure 3. Suppression of ductal growth in pubescent MMTV-RbΔK transgenic mice. Whole-mount staining of 5- and 7-wk-old pubescent MMTV-RbΔp34#27 (A and B) and MMTV-RbΔK11#29 (C and D) transgenic and control females. LN, lymph node. (E) The distance from the endbuds to the lymph nodes in 7-wk-old wild-type females was set at 100%. The average growth rates of endbuds in three transgenic females and three wild-type littermates were plotted against this value for each time point. PCNA staining of sections through endbuds of 6-wk-old MMTV-RbΔp34#24 (F and G) and MMTV-RbΔK11#29 (H and I) transgenic females and control wild-type littermates. Arrows indicate PCNA-positive nuclei. (J) Quantitative analysis of the relative proliferation (PCNA-positive nuclei) in TEBs at the indicated stages. For each time point, two sections each from three transgenic and three wild-type mice were analyzed. The average number of PCNA-positive nuclei in the control wild-type females for MMTV-RbΔK11 was set at 100%. Bars in E and J indicate standard deviation.
Figure 3. Suppression of ductal growth in pubescent MMTV-RbΔK transgenic mice. Whole-mount staining of 5- and 7-wk-old pubescent MMTV-RbΔp34#27 (A and B) and MMTV-RbΔK11#29 (C and D) transgenic and control females. LN, lymph node. (E) The distance from the endbuds to the lymph nodes in 7-wk-old wild-type females was set at 100%. The average growth rates of endbuds in three transgenic females and three wild-type littermates were plotted against this value for each time point. PCNA staining of sections through endbuds of 6-wk-old MMTV-RbΔp34#24 (F and G) and MMTV-RbΔK11#29 (H and I) transgenic females and control wild-type littermates. Arrows indicate PCNA-positive nuclei. (J) Quantitative analysis of the relative proliferation (PCNA-positive nuclei) in TEBs at the indicated stages. For each time point, two sections each from three transgenic and three wild-type mice were analyzed. The average number of PCNA-positive nuclei in the control wild-type females for MMTV-RbΔK11 was set at 100%. Bars in E and J indicate standard deviation.CC BY-NC-SA · PubMed Central
Figure 4. Precocious differentiation of the mammary epithelium in nulliparous MMTV-RbΔK transgenic females. Whole-mount analyses of 13-wk-old nulliparous transgenic and control females (A and B); PCNA staining (C and D); IHC for β-casein (E and F). Whole-mount hematoxylin staining of 14-mo-old control (G) and two nulliparous transgenic (H and I) females (40×). Note the dilated ducts (arrow). (J) Higher magnification (70×) of the mammary gland in I, showing a lobuloalveolar-like structure (arrow). (K and M) H-E staining of mammary glands of 14-mo-old transgenic (M) and wild-type (K) littermate female. (L) H-E staining of a mammary gland from a 17.5-d-old pregnant wild-type female (P17.5). Note the similarity between nulliparous transgenic (M) and pregnant wild-type glands (L). (N–P) IHC of β-casein in mammary glands of 14-mo-old nulliparous wild-type (N) and two transgenic (O and P) females. (Q) RT-PCR analysis of β-casein expression in 9–20-wk-old nulliparous transgenic and control females. (R) Western blot analysis of β-casein expression in transgenic (TG) and wild-type (WT) females.
Figure 4. Precocious differentiation of the mammary epithelium in nulliparous MMTV-RbΔK transgenic females. Whole-mount analyses of 13-wk-old nulliparous transgenic and control females (A and B); PCNA staining (C and D); IHC for β-casein (E and F). Whole-mount hematoxylin staining of 14-mo-old control (G) and two nulliparous transgenic (H and I) females (40×). Note the dilated ducts (arrow). (J) Higher magnification (70×) of the mammary gland in I, showing a lobuloalveolar-like structure (arrow). (K and M) H-E staining of mammary glands of 14-mo-old transgenic (M) and wild-type (K) littermate female. (L) H-E staining of a mammary gland from a 17.5-d-old pregnant wild-type female (P17.5). Note the similarity between nulliparous transgenic (M) and pregnant wild-type glands (L). (N–P) IHC of β-casein in mammary glands of 14-mo-old nulliparous wild-type (N) and two transgenic (O and P) females. (Q) RT-PCR analysis of β-casein expression in 9–20-wk-old nulliparous transgenic and control females. (R) Western blot analysis of β-casein expression in transgenic (TG) and wild-type (WT) females.CC BY-NC-SA · PubMed Central
Figure 5. Hyperplastic nodules in the mammary gland of MMTV-RbΔK transgenic mice. Low power views (8×) of whole-mount staining of #4 right inguinal mammary glands from 13.5-mo-old nulliparous wild-type female (A) and MMTV-RbΔp34#16 transgenic littermate (B). Arrows point to hyperplastic nodules. (C and D) 13.5-mo-old multiparous wild-type and MMTV-RbΔK11#29 transgenic littermate gland with a hyperplastic nodule. (E and F) High power views of representative hyperplastic nodules (arrows) in independent MMTV-RbΔp34 transgenic lines.
Figure 5. Hyperplastic nodules in the mammary gland of MMTV-RbΔK transgenic mice. Low power views (8×) of whole-mount staining of #4 right inguinal mammary glands from 13.5-mo-old nulliparous wild-type female (A) and MMTV-RbΔp34#16 transgenic littermate (B). Arrows point to hyperplastic nodules. (C and D) 13.5-mo-old multiparous wild-type and MMTV-RbΔK11#29 transgenic littermate gland with a hyperplastic nodule. (E and F) High power views of representative hyperplastic nodules (arrows) in independent MMTV-RbΔp34 transgenic lines.CC BY-NC-SA · PubMed Central
Figure 6. WAP-RbΔp34 transgenic mice also develop hyperplastic nodules. (A) Schematic structure of the WAP-RbΔp34 transgene. (B) RT-PCR analysis of WAP-RbΔp34 expression in an 18.5-d-old pregnant transgenic female. (C and D) Whole-mount analysis of 12-mo-old nulliparous wild-type (C) and WAP-RbΔp34#44 transgenic (D) glands (8×). (E) Representative high power view of hyperplastic nodules in a WAP-RbΔp34#61 transgenic female (40×). (F) H-E staining of cross-section through a hyperplastic nodule. Arrows in D and E point to hyperplastic nodules.
Figure 6. WAP-RbΔp34 transgenic mice also develop hyperplastic nodules. (A) Schematic structure of the WAP-RbΔp34 transgene. (B) RT-PCR analysis of WAP-RbΔp34 expression in an 18.5-d-old pregnant transgenic female. (C and D) Whole-mount analysis of 12-mo-old nulliparous wild-type (C) and WAP-RbΔp34#44 transgenic (D) glands (8×). (E) Representative high power view of hyperplastic nodules in a WAP-RbΔp34#61 transgenic female (40×). (F) H-E staining of cross-section through a hyperplastic nodule. Arrows in D and E point to hyperplastic nodules.CC BY-NC-SA · PubMed Central
Figure 7. Mammary adenocarcinomas in MMTV-RbΔK and WAP-RbΔp34 transgenic mice and loss of transgene expression. Histology of mammary adenocarcinomas. (A) Whole-mount staining of a palpable mammary adenocarcinoma in a 13.5-mo-old nulliparous MMTV-RbΔp34#27 transgenic female, showing the periphery of a tumor with invasion into the ducts. (B) Mammary adenocarcinoma with multiple cystic areas in a 12-mo-old multiparous MMTV-RbΔp34#24 transgenic female. (C) Well-differentiated tubulo-acinar mammary adenocarcinoma in a 12-mo-old nulliparous WAP-RbΔp34#44 transgenic female. (D) Well-differentiated papillary mammary adenocarcinoma with peripheral growth of basaloid cells and radiating keratinization in a 14-mo-old multiparous WAP-RbΔp34#61 transgenic female. (E and F) Papillary mammary adenocarcinoma and mammary adenocarcinoma in the first and third glands, respectively, from a multiparous 18-mo-old MMTV-RbΔK11#29 transgenic female. (G) Multiple lesions in an MMTV-RbΔK11#29 retired breeder. (H and K) High power magnifications of the lesions shown in (G). H–J are mammary adenocarcinomas; K is an enlarged lobuloalveolar-like structure. Tumors in A–F were ∼1–2 cm in length and significantly larger than H. Analysis of mammary adenocarcinomas. (L–M) PCNA staining demonstrating high mitotic index (M, arrows) in a tumor relative to a tumor-free gland in the same transgenic female (L). (N) Positive staining of mammary adenocarcinomas with antikeratin antibody, an epithelial marker. (O and P) RT-PCR analysis of transgene (O) and keratin 18 (P) expression in tumor biopsies and a derived cell line. Adenocarcinoma biopsies from the tumors shown in E and F (1 and 2); mammary gland from a MMTV-RbΔK11 transgenic female (3); cell line derived from the mammary adenocarcinoma in F (4); mammary gland from a wild-type female (5). The + and – signs indicate the presence or absence of reverse transcriptase.
Figure 7. Mammary adenocarcinomas in MMTV-RbΔK and WAP-RbΔp34 transgenic mice and loss of transgene expression. Histology of mammary adenocarcinomas. (A) Whole-mount staining of a palpable mammary adenocarcinoma in a 13.5-mo-old nulliparous MMTV-RbΔp34#27 transgenic female, showing the periphery of a tumor with invasion into the ducts. (B) Mammary adenocarcinoma with multiple cystic areas in a 12-mo-old multiparous MMTV-RbΔp34#24 transgenic female. (C) Well-differentiated tubulo-acinar mammary adenocarcinoma in a 12-mo-old nulliparous WAP-RbΔp34#44 transgenic female. (D) Well-differentiated papillary mammary adenocarcinoma with peripheral growth of basaloid cells and radiating keratinization in a 14-mo-old multiparous WAP-RbΔp34#61 transgenic female. (E and F) Papillary mammary adenocarcinoma and mammary adenocarcinoma in the first and third glands, respectively, from a multiparous 18-mo-old MMTV-RbΔK11#29 transgenic female. (G) Multiple lesions in an MMTV-RbΔK11#29 retired breeder. (H and K) High power magnifications of the lesions shown in (G). H–J are mammary adenocarcinomas; K is an enlarged lobuloalveolar-like structure. Tumors in A–F were ∼1–2 cm in length and significantly larger than H. Analysis of mammary adenocarcinomas. (L–M) PCNA staining demonstrating high mitotic index (M, arrows) in a tumor relative to a tumor-free gland in the same transgenic female (L). (N) Positive staining of mammary adenocarcinomas with antikeratin antibody, an epithelial marker. (O and P) RT-PCR analysis of transgene (O) and keratin 18 (P) expression in tumor biopsies and a derived cell line. Adenocarcinoma biopsies from the tumors shown in E and F (1 and 2); mammary gland from a MMTV-RbΔK11 transgenic female (3); cell line derived from the mammary adenocarcinoma in F (4); mammary gland from a wild-type female (5). The + and – signs indicate the presence or absence of reverse transcriptase.CC BY-NC-SA · PubMed Central
Figure 8. Extended survival of the mammary epithelium in MMTV-RbΔK transgenic mice. (A–G) Effects of activated Rb on day 6 of the first postlactational involution. TUNEL analysis (A and C) and β-casein IHC (B and D) were performed on adjacent sections (A and B and C and D) from MMTV-RbΔK11#29 transgenic females at day 6 of first involution. Note the inverse correlation between the presence of apoptotic nuclei (A, black arrows) and the expression of β-casein (D, white arrows) in the same lobules. (E) Relative apoptosis was determined by counting TUNEL-positive nuclei in multiple random areas under 400× magnification. (F and G) RT-PCR and Western blot analyses of milk gene expression in transgenic and wild-type littermate females at day 6 of first involution. The level of milk genes was slightly higher in the transgenic females. (H and M) Enlarged lobuloalveolar-like structures in multiparous retired MMTV-RbΔK11#29 transgenic breeders but not in control littermates. (H–K) H-E staining (H and I, 10×; J and K, 40×). (L and M) Gomori trichrome staining for collagen (L, 126×; M, 63×). ECM is present in transgenic (black arrow) but not in wild-type females (white arrow). (N–P) Western blot analyses of the indicated proteins in multiparous retired breeders (N and P) and 4-mo-old nulliparous females (O).
Figure 8. Extended survival of the mammary epithelium in MMTV-RbΔK transgenic mice. (A–G) Effects of activated Rb on day 6 of the first postlactational involution. TUNEL analysis (A and C) and β-casein IHC (B and D) were performed on adjacent sections (A and B and C and D) from MMTV-RbΔK11#29 transgenic females at day 6 of first involution. Note the inverse correlation between the presence of apoptotic nuclei (A, black arrows) and the expression of β-casein (D, white arrows) in the same lobules. (E) Relative apoptosis was determined by counting TUNEL-positive nuclei in multiple random areas under 400× magnification. (F and G) RT-PCR and Western blot analyses of milk gene expression in transgenic and wild-type littermate females at day 6 of first involution. The level of milk genes was slightly higher in the transgenic females. (H and M) Enlarged lobuloalveolar-like structures in multiparous retired MMTV-RbΔK11#29 transgenic breeders but not in control littermates. (H–K) H-E staining (H and I, 10×; J and K, 40×). (L and M) Gomori trichrome staining for collagen (L, 126×; M, 63×). ECM is present in transgenic (black arrow) but not in wild-type females (white arrow). (N–P) Western blot analyses of the indicated proteins in multiparous retired breeders (N and P) and 4-mo-old nulliparous females (O).CC BY-NC-SA · PubMed Central
Figure 9. Models for the effects of inactivation versus activation of the Rb pathway. (A) Loss of Rb leads to ectopic DNA synthesis, increased cell death, and incomplete differentiation. Unscheduled cell proliferation is often counteracted by apoptosis but in some cell types results in neoplastic transformation, that is, retinoblastoma in human and pituitary tumors in the mouse. Inhibition of proapoptotic pathways (e.g., inactivation of p53) cooperates with loss of Rb during cancer progression. Impaired differentiation in Rb-deficient mice may be an indirect effect due to the ectopic cell proliferation and apoptosis that perturb the differentiation program. Alternatively, Rb may be required for the onset of terminal differentiation via direct or indirect stimulation of differentiation factors (e.g., glucocorticoid receptor, C/EBP, MyoD, etc.). (B) As shown in this study, activation of Rb in the mammary gland results in suppression of cell proliferation, precocious differentiation, extended survival of the mammary epithelium, and mammary tumors. The precocious differentiation may reflect the ability of activate Rb to extend the survival of differentiated cells and/or to directly promote differentiation. We propose that inhibition of apoptosis by active Rb can lead to the accumulation of oncogenic alterations and neoplastic transformation in susceptible tissues such as the mammary epithelium.
Figure 9. Models for the effects of inactivation versus activation of the Rb pathway. (A) Loss of Rb leads to ectopic DNA synthesis, increased cell death, and incomplete differentiation. Unscheduled cell proliferation is often counteracted by apoptosis but in some cell types results in neoplastic transformation, that is, retinoblastoma in human and pituitary tumors in the mouse. Inhibition of proapoptotic pathways (e.g., inactivation of p53) cooperates with loss of Rb during cancer progression. Impaired differentiation in Rb-deficient mice may be an indirect effect due to the ectopic cell proliferation and apoptosis that perturb the differentiation program. Alternatively, Rb may be required for the onset of terminal differentiation via direct or indirect stimulation of differentiation factors (e.g., glucocorticoid receptor, C/EBP, MyoD, etc.). (B) As shown in this study, activation of Rb in the mammary gland results in suppression of cell proliferation, precocious differentiation, extended survival of the mammary epithelium, and mammary tumors. The precocious differentiation may reflect the ability of activate Rb to extend the survival of differentiated cells and/or to directly promote differentiation. We propose that inhibition of apoptosis by active Rb can lead to the accumulation of oncogenic alterations and neoplastic transformation in susceptible tissues such as the mammary epithelium.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

Metadata

Authors
Jiang, Z., & Zacksenhaus, E.
Affiliations
University Health Network (CA)
Corresponding author
Zacksenhaus, Eldad
Venue
The Journal of Cell Biology
Published
2002-01-03
Volume
156
Issue
1
Pages
185-198
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2114749101
Cited by
55
References
83
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
2.37
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
retinoblastoma protein, mammary gland, mammary adenocarcinoma, apoptosis, cell proliferation, E2F1, IGF-1 receptor, Akt signaling, transgenic mice, tumor suppressor activation, cancer therapy
MeSH terms
Adenocarcinoma, Alleles, Animals, Breast, Cell Differentiation, Cell Division, Cell Survival, Female, Hyperplasia, Mammary Tumor Virus, Mouse, Mice, Transgenic, Milk Proteins, Models, Biological, Mutation, Parity, Phosphorylation, Pregnancy, RNA, Messenger, Mammary Neoplasms, Animal, Retinoblastoma Protein, In Situ Hybridization, Gene Expression Regulation, Developmental, Transgenes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.